MANNKIND CORP - 8-K Filing
MannKind Corp raised $50.0 million in a private placement of common stock and warrants; FDA approved Furoscix ReadyFlow for edema treatment (Items: 3.02 Unregistered Sales of Equity Securities, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $MNKD